CARM1 and acute myeloid leukemia: Guo et al. also modified the structure of a previously discovered weak dual PRMT4/PRMT6 inhibitor to develop a novel and highly selective PRMT4 inhibitor (compound 49), which induced cell cycle arrest and apoptosis in AML cell lines [126].